Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection.
Kushala W M AbeysekeraHedvig KartesziAmanda ClarkFiona H GordonPublished in: BMJ case reports (2020)
Intra-abdominal thromboses are a poorly characterised thrombotic complication of COVID-19 and are illustrated in this case. A 42-year-old man with chronic hepatitis B (undetectable viral load, FibroScan 7.4 kPa) developed fever and cough in March 2020. 14 days later, he developed right upper quadrant pain. After being discharged with reassurance, he re-presented with worsening pain on symptom day 25. Subsequent abdominal ultrasound suggested portal vein thrombosis. CT of the abdomen confirmed portal and mid-superior mesenteric vein thromboses. Concurrent CT of the chest suggested COVID-19 infection. While reverse transcription PCR was negative, subsequent antibody serology was positive. Thrombophilia screen excluded inherited and acquired thrombophilia. Having been commenced on apixaban 5 mg two times per day, he is currently asymptomatic. This is the first case of COVID-19-related portomesenteric thrombosis described in the UK. A recent meta-analysis suggests 9.2% of COVID-19 cases develop abdominal pain. Threshold for performing abdominal imaging must be lower to avoid this reversible complication.
Keyphrases
- coronavirus disease
- sars cov
- abdominal pain
- pulmonary embolism
- systematic review
- chronic pain
- respiratory syndrome coronavirus
- computed tomography
- pain management
- contrast enhanced
- neuropathic pain
- image quality
- magnetic resonance imaging
- dual energy
- hepatitis b virus
- high resolution
- atrial fibrillation
- positron emission tomography
- case report
- venous thromboembolism
- meta analyses
- high throughput
- transcription factor
- liver fibrosis
- rectal cancer
- locally advanced
- case control
- contrast enhanced ultrasound